PTEN and prostate carcinoma: ZFHX3 has been established as a tumor suppressor in prostate cancer in our previous studies, as its gene undergoes frequent somatic mutations in advanced prostate cancer33,34 and its deletion in mouse prostates causes neoplastic lesions and promotes Pten deletion-induced tumorigenesis35,36.